A novel targeted GPC3/CD3 bispecific antibody for the treatment hepatocellular carcinoma
出版年份 2020 全文链接
标题
A novel targeted GPC3/CD3 bispecific antibody for the treatment hepatocellular carcinoma
作者
关键词
-
出版物
CANCER BIOLOGY & THERAPY
Volume -, Issue -, Pages 1-7
出版商
Informa UK Limited
发表日期
2020-04-03
DOI
10.1080/15384047.2020.1743158
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bispecific antibody based therapeutics: Strengths and challenges
- (2018) Archana Thakur et al. BLOOD REVIEWS
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Cancer immune therapy for lymphoid malignancies: recent advances
- (2018) Uffe Klausen et al. Seminars in Immunopathology
- Glypican-3 Specific Antibody Drug Conjugates Targeting Hepatocellular Carcinoma
- (2018) Ying Fu et al. HEPATOLOGY
- Recent advances of bispecific antibodies in solid tumors
- (2017) Shengnan Yu et al. Journal of Hematology & Oncology
- Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
- (2017) Fubo Zhou et al. MEDICINAL RESEARCH REVIEWS
- Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma
- (2017) Nan Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors
- (2017) Takahiro Ishiguro et al. Science Translational Medicine
- Treatment of hepatocellular carcinoma with a GPC3-targeted bispecific T cell engager
- (2017) Yanyu Bi et al. Oncotarget
- Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma
- (2017) Zhiwu Jiang et al. Frontiers in Immunology
- Facile Affinity Maturation of Antibody Variable Domains Using Natural Diversity Mutagenesis
- (2017) Kathryn E. Tiller et al. Frontiers in Immunology
- Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma
- (2016) Ghassan K. Abou-Alfa et al. JOURNAL OF HEPATOLOGY
- A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo
- (2016) S Hipp et al. LEUKEMIA
- MOR209/ES414, a Novel Bispecific Antibody Targeting PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer
- (2016) G. Hernandez-Hoyos et al. MOLECULAR CANCER THERAPEUTICS
- Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
- (2016) Yu Sawada et al. OncoImmunology
- FDA Approval: Blinatumomab
- (2015) D. Przepiorka et al. CLINICAL CANCER RESEARCH
- Bispecific antibodies and their applications
- (2015) Gaowei Fan et al. Journal of Hematology & Oncology
- A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19+tumor cells
- (2015) Uwe Reusch et al. mAbs
- Improving target cell specificity using a novel monovalent bispecific IgG design
- (2015) Yariv Mazor et al. mAbs
- Structural design of disialoganglioside GD2 and CD3-bispecific antibodies to redirect T cells for tumor therapy
- (2014) Ming Cheng et al. INTERNATIONAL JOURNAL OF CANCER
- CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas
- (2014) Michael D Oberst et al. mAbs
- Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma
- (2013) M. Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regression of Human Prostate Cancer Xenografts in Mice by AMG 212/BAY2010112, a Novel PSMA/CD3-Bispecific BiTE Antibody Cross-Reactive with Non-Human Primate Antigens
- (2012) M. Friedrich et al. MOLECULAR CANCER THERAPEUTICS
- Heavy chain-only antibodies and tetravalent bispecific antibody neutralizing Staphylococcus aureus leukotoxins
- (2011) B.-J. Laventie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
- (2008) T. Ishiguro et al. CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started